|
Tercica, Inc. Announces Follow-On Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Feb 08, 2005 -- Tercica, Inc. (Nasdaq: TRCA)
announced today a follow-on offering of 6,000,000 shares of its common stock
at a public offering price of $8.00 per share. All of the shares are being
offered by Tercica.
The sole book running manager of the offering was Lehman Brothers. SG Cowen
served as joint lead manager. Robert W. Baird & Co., Friedman, Billings,
Ramsey and Harris Nesbitt were co-managers. Tercica has granted the
underwriters a 30-day option to purchase up to an additional 900,000 shares
of its common stock. Copies of the final prospectus relating to the offering
may be obtained from Lehman Brothers c/o ADP Financial Services, Integrated
Distribution Services, 1155 Long Island Avenue, Edgewood, NY 11717;
631-254-7106 or by email request to
sabrina_neat@adp.com or
monica_castillo@adp.com.
About Tercica
Tercica is a biopharmaceutical company focused on the development and
commercialization of recombinant human insulin-like growth factor-1 for the
treatment of short stature and other metabolic disorders.
This press release shall not constitute an offer to sell
or the solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
SOURCE Tercica, Inc.
Kimberly Kraemer, Sr. Director, Corporate Communications & Investor
Relations of
Tercica, Inc., +1-650-624-4949, or
kimberly.kraemer@tercica.com
|
|
